Don't Just Read the News, Understand It.
Published loading...Updated

Weight loss jab warning from health watchdog over unborn babies

  • The MHRA issued a warning on June 4, 2025, after more than 40 pregnancy reports among women using GLP-1 weight-loss and diabetes drugs in the UK.
  • This alert followed concerns the drugs, including Ozempic, Mounjaro, Wegovy, Saxenda, and Victoza, lack safety data for pregnancy and must not be taken while pregnant.
  • The MHRA emphasized women must use effective contraception—such as pills, implants, coils, or condoms—and stop the medicine if pregnancy occurs, noting Mounjaro may reduce pill effectiveness.
  • The agency reported 26 cases linked to Mounjaro, eight to semaglutide , and nine to liraglutide , urging users to avoid unregulated sellers and consult health professionals.
  • This warning suggests patients and healthcare providers must prioritize contraception and drug safety to prevent unintended pregnancies and potential fetal harm from these medications.
Insights by Ground AI
Does this summary seem wrong?
Podcasts & Opinions

42 Articles

All
Left
5
Center
11
Right
5
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 52% of the sources are Center
52% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

The Independent broke the news in London, United Kingdom on Wednesday, June 4, 2025.
Sources are mostly out of (0)